＋
R&D, procurement and project leads in the medical device industry are constantly confronted with several core pain points: failure to obtain overseas registration due to unsatisfactory product biocompatibility, elevated assembly costs caused by manual trimming of flash on silicone parts, product deformation and failure after multiple sterilization cycles, significant dimensional variation of ultra-thin micro-precision structures during mass production, and uncontrollable mold investment costs for small-batch orders.
Conventional high-consistency rubber (HCR) compression molding can hardly meet the compliant mass production requirements of Class II minimally invasive consumables, in vitro diagnostic products and respiratory drug delivery devices exported to Europe and the United States.
This article draws on a dedicated platinum-catalyzed LSR mass-production cleanroom line meeting ISO Class 100,000 standards, fully retaining the complete compliant technical system for liquid silicone rubber. It objectively breaks down process advantages, application limitations and cost trade-off logic, specifically addressing the three core pain points of medical device manufacturers: mass production, regulatory registration and cost control, and providing actionable technical references for material and process selection decisions.
Whether medical silicone can successfully pass FDA and CE registrations hinges fundamentally on the biocompatibility and sterilization stability of raw materials. Many manufacturers have faced registration rejections due to excessive extractables from conventional cured silicone and degraded material performance after irradiation. We adopt imported platinum-addition LSR raw materials across all product lines to eliminate clinical risks at the source, supporting the development of devices for short-term and long-term human tissue contact.
The raw materials have fully passed the complete set of biocompatibility tests specified in USP Class VI, including acute systemic toxicity, intracutaneous irritation and subcutaneous implantation tests. They are non-cytotoxic, non-hemolytic and non-sensitizing, free of latex, phthalates and animal-derived ingredients, and eliminate risks of TSE/BSE contamination. Original manufacturer COA material certificates and third-party biocompatibility test reports can be provided along with shipments. To meet the demands of high-end export customers, we can coordinate extractables and leachables (E&L) testing for finished products to complete full documentation for regulatory registration.
Platinum-cured LSR features a stable cross-linked molecular structure. Under normal service conditions, it is compatible with three mainstream sterilization methods: 121°C autoclave steam, ethylene oxide (EO), and standard-dose gamma irradiation. No yellowing, cracking or dimensional shift occurs within the specified number of sterilization cycles.
Objective Process Limitation Statement: Continuous excessive cycles of high-temperature autoclaving and repeated high-dose gamma irradiation will cause slight mechanical property degradation and dimensional creep. During the R&D phase, we can offset such deviations via wall thickness optimization and structural reinforcement design to proactively prevent reliability failure risks after the customer’s product launch.
Many R&D engineers hold a preconceived notion that ISO Class 7 cleanrooms are mandatory for microfluidic and ultra-thin precision minimally invasive components, yet this actually leads to overinvestment, limited production capacity and doubled operating costs.
ISO Class 100,000 cleanrooms represent the current optimal balanced solution for mass production of medical LSR products. They fully comply with GMP manufacturing specifications for Class I and Class II medical devices intended for human contact, with particulate and microbial indicators meeting routine factory audit standards in China, Europe and the United States. Meanwhile, they avoid the drawbacks of ISO Class 7 cleanrooms, including excessive air exchange rates, high sensitivity to temperature and humidity fluctuations, and persistently high long-term operational costs, helping customers lower per-unit production costs.
Our factory’s dedicated LSR injection molding lines strictly follow ISO Class 100,000 cleanroom control standards and feature a full-process contamination blocking system:
Three-stage air filtration: primary filter + medium-efficiency filter + terminal HEPA filter with a 99.97% filtration efficiency for 0.3μm particles. The cleanroom maintains constant temperature and humidity alongside stable pressure gradients to prevent dust adsorption by static electricity and silicone shrinkage deviation caused by temperature and humidity fluctuations.
Full-process cleanroom control: Mandatory air shower disinfection for all personnel; sealed low-temperature (4–10°C) closed conveying of raw materials; physical separation of molding, temporary storage and inspection zones to reduce microbial contamination from bare-hand manual contact.
Complete traceable records: Regular testing of airborne viable bacteria, settle plate microorganisms and airborne particles is performed, and all cleanroom test reports are archived long-term and available for immediate access during customer GMP audits and third-party inspections.
Leveraging standardized cleanroom production control capabilities, we can stably mold microfluidic valves with ultra-thin walls as thin as 0.05 mm, with consistent dimensional tolerance controlled within ±0.01 mm across mass production runs. Finished parts feature smooth surfaces that drastically cut post-processing procedures.
Many medical device manufacturers have long adopted conventional HCR compression molded silicone, suffering three recurring losses: labor costs for flash trimming, high batch defect rates, and limited material compliance. Nevertheless, LSR is not a universal replacement solution for all scenarios. We objectively recommend processes based on customers’ order volume, product structure and budget, and refrain from blind sales promotion.
Adopting precision needle-valve cold runner molds enables accurate control of shot volume per cavity. For flat parts and general thin-wall precision structures, near-flash-free molding can be achieved. No manual trimming or polishing is required after demolding, which drastically cuts labor costs for downstream assembly and substantially reduces overall mass production expenses.
The full production line operates in an automated closed loop. Digital records are generated throughout raw material proportioning and mixing, high-pressure injection molding, high-temperature vulcanization and automatic ejection. SPC statistical process control is implemented to deliver consistent dimensional and mechanical properties across large batches, making it suitable for long-term standardized bulk orders from European and American medical device brands.
To avoid disputes arising from mold development and mass production at a later stage, we truthfully state the applicable limitations of the process and inform customers synchronously during the preliminary DFM review for transparent process selection:
1. Cost Threshold: The investment for dedicated LSR cold runner molds and low-temperature metering injection equipment is far higher than that of conventional compression molding. This process is more suitable for mass-production products with an annual order volume of over 50,000 pieces. Compression molding offers higher cost performance for small-batch R&D samples and diversified small orders.
2. Process Control Threshold: LSR two-component mixing ratio, barrel temperature and injection speed are extremely sensitive parameters. Minor deviations may easily lead to defects such as air bubbles, trapped air and uneven vulcanization. Our factory has full-time molding engineers to conduct full-process control to ensure consistent quality between prototypes and mass-produced parts.
3. Structural Molding Limitations: The yield rate is relatively low for parts with deep blind holes, drastic wall thickness differences, or complex undercut irregular shapes. Delamination and debonding tend to occur when overmolding metal or hard plastic inserts. Compression molding is preferred for such structures. If LSR production is still required, we will provide a special structural optimization solution.
4. Risk of Raw Material Loss: Mixed two-part AB adhesives have a fixed pot life. Prolonged production line downtime will easily cause premature curing and scrap of mixed materials, resulting in relatively higher material loss costs for small-batch trial production.
For years, supported by ISO Class 10 cleanroom LSR production lines, we have mass-manufactured a wide range of precision silicone components for Class I and Class II medical devices. All products undergo First Article Inspection (FAI), in-process patrol inspections and full dimensional testing of finished goods. Complete test reports are supplied for each batch to assist customers with new device registration and market launch.
1.Respiratory Diagnosis & Treatment Consumables: silicone cushions for non-invasive ventilator masks, ventilation sealing gaskets, minimally invasive buffer silicone components for respiratory tracts.
2.Drug Delivery & Infusion Devices: insulin pump diaphragms, one-way sealing valves for infusion sets, precision silicone diaphragms for micro-dosing.
3.Minimally Invasive Interventional Instruments: Overmolded anti-slip handles for puncture devices, buffer liners for minimally invasive surgeries, precision microfluidic valves.
4.In Vitro Diagnostic (IVD) Equipment: Sealing valves for nucleic acid detection kits, ultra-thin silicone sealing assemblies for biochips.
5. Medical Auxiliary Accessories: Silicone buffer pads for short-term implantable devices, sterile elastic isolation components.
Full version for brochures & technical profiles: New medical device development is characterized by long R&D cycles, cumbersome registration documentation, and stringent stability standards for mass deliveries. We have built a standardized development pipeline to address two core demands: sample validation for R&D engineers and mass production for procurement teams. A dedicated project engineer provides one-on-one dedicated coordination throughout the entire project lifecycle.
We accept customers’ 2D/3D drawings or physical samples. Our technical team takes product wall thickness, sterilization methods, annual order volume and overseas registration requirements into comprehensive consideration to objectively compare costs, yield rates and lead times between LSR injection molding and traditional compression molding processes. We forecast potential molding defects, dimensional deviations and compliance risks in advance and provide implementable optimization suggestions to prevent unnecessary capital losses caused by customers’ blind mold development.
For standard-structured regular products, LSR molded samples will be ready within 7 working days. For microfluidic parts, complex overmolded components and special-shaped products with multiple undercuts, we will inform customers of the exact sample preparation cycle right after review, with no false delivery time commitments.
Upon sample delivery, we provide supporting documents including COA of imported platinum-cured LSR materials, USP Class VI biocompatibility reports, and full dimensional inspection data sheets of finished products. For overseas export clients, E&L extractables & leachables testing coordination is available on demand. The complete documentation package can be directly used for product registration and third-party factory audits.
After the customer’s samples pass all performance, dimensional and sterilization tests, we will launch the fabrication of professional mass-production cold runner molds. Cooling, venting and sealing structures are optimized to enable stable long-lifecycle production.Once the molds are finished, small-batch trial runs will be conducted to finalize the complete set of injection molding process parameters and standard SOPs for higher molding yield.After full verification, production will move to automated mass manufacturing in an ISO Class 100,000 cleanroom. All products are individually packed under clean conditions, with full traceability of every production batch to ensure consistent quality across long-term multi-batch deliveries.
Against the industry backdrop of increasingly stringent medical device compliance audits both domestically and overseas as well as the trend toward higher product precision, the combination of ISO Class 100,000 cleanrooms and platinum-cured LSR cold runner injection molding delivers a cost-effective mass production solution for high-volume precision silicone components requiring superior biosafety levels. It specifically addresses core pain points associated with traditional compression molding, such as high costs from flash waste, poor batch consistency, non-compliant materials for overseas registration, and sterilization failure risks.
We adhere to transparent process and mold selection principles: LSR delivers outstanding advantages for high-precision, high-volume applications, yet it is not suitable for all silicone products. Trial molds are solely for R&D verification with short service lives and unfit for commercial mass production, so dedicated mass-production molds must be developed separately. For low-volume, complex special-shaped and thick-wall consumables, traditional compression molding can help customers cut mold-opening and unit production costs. Our core competitive edge that sets us apart from peers lies in objectively recommending solutions from customers’ perspectives — covering R&D progress, cost reduction & efficiency improvement in procurement, smooth registration, and risk avoidance of mass production failures.
钜泰拥有一支经验丰富、技术娴熟的设计师、工程师和技术人员团队。高质量标准、有竞争力的价格、准时交货以及负责的售后服务是我们遵循的原则，也是与国内外客户建立相互信任和信息的保证。毕竟，钜泰核心价值始终在于——让我们的客户始终保持行业领先。
如果您有任何需要测试并推向市场的新产品设计，请随时与我们联系。我们将尽快回复您。
